The immunopeptidomic landscape of ovarian carcinomas

Immunotherapies, particularly checkpoint inhibitors, have set off a revolution in cancer therapy by releasing the power of the immune system. However, only little is known about the antigens that are essentially presented on cancer cells, capable of exposing them to immune cells. Large-scale HLA lig...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuster, Heiko, Peper, Janet K., Bösmüller, Hans-Christian, Röhle, Kevin, Backert, Linus, Bilich, Tatjana, Ney, Britta, Löffler, Markus W., Kowalewski, Daniel J., Trautwein, Nico, Rabsteyn, Armin, Engler, Tobias, Braun, Sabine, Haen, Sebastian P., Walz, Juliane S., Schmid-Horch, Barbara, Brucker, Sara Y., Wallwiener, Diethelm, Kohlbacher, Oliver, Fend, Falko, Rammensee, Hans-Georg, Stevanović, Stefan, Staebler, Annette, Wagner, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2017
Materias:
PNAS Plus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699044/
https://www.ncbi.nlm.nih.gov/pubmed/29093164
http://dx.doi.org/10.1073/pnas.1707658114

Ejemplares similares

Ejemplares similares